Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8 Purity>98.0% (GC) Lenvatinib Mesylate Intermediate Factory

Kufotokozera Kwachidule:

Dzina la Mankhwala: Methyl 4-Amino-2-Methoxybenzoate

CAS: 27492-84-8

Kuyera: > 98.0% (GC)

Maonekedwe: Ufa Woyera mpaka Woyera kapena Makristalo

Pakati pa Lenvatinib Mesylate CAS 857890-39-2

E-Mail: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Chemical Properties:

Dzina la Chemical Methyl 4-Amino-2-Methoxybenzoate
Mawu ofanana ndi mawu 4-Amino-2-Methoxybenzoic Acid Methyl Ester;Methyl 4-Amino-o-Anisate;4-Amino-o-Anisic Acid Methyl Ester
Nambala ya CAS 27492-84-8
Nambala ya CAT Mtengo wa RF-PI1974
Stock Status Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula C9H11NO3
Kulemera kwa Maselo 181.19
Kuchulukana 1.179±0.060 g/cm3
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera mpaka Woyera kapena Makristalo
Kuyera / Kusanthula Njira >98.0% (GC)
Kuyera / Kusanthula Njira 97.5 ~ 102.5 (Nonaqueous Titration)
Melting Point 157.0 ~ 161.0 ℃
Kutaya pa Kuyanika <1.00%
Zonse Zonyansa <2.0%
Infrared Spectrum Zimagwirizana ndi Kapangidwe
Proton NMR Spectrum Zimagwirizana ndi Kapangidwe
Test Standard Enterprise Standard
Kugwiritsa ntchito Pakati pa Lenvatinib Mesylate (CAS: 857890-39-2)

Phukusi & Kusungira:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala

Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi

Ubwino:

1

FAQ:

Ntchito:

Methyl 4-Amino-2-Methoxybenzoate (CAS: 27492-84-8) angagwiritsidwe ntchito ngati wapakatikati wa Lenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib ndi mankhwala a khansa ya chithokomiro opangidwa ndi Eisai Corporation yaku Japan (Code: E7080), ya inhibitor ya oral multi-receptor tyrosine kinase (RTK) ndipo imatha kuletsa ntchito ya kinase ya vascular endothelial growth factor (VEGF) Receptors VEGFR1 ( FLT1), VEGFR2 (KDR), ndi VEGFR3 (FLT4).Lenvatinib ingalepheretsenso kukhudzidwa kwa ma RTK ena mu pathological angiogenesis, kukula kwa chotupa, ndi kukula kwa khansa kupatulapo ntchito zawo zachibadwa zama cell kuphatikizapo fibroblast growth factor (FGF) zolandilira FGFR1, 2, 3, ndi 4;Kukula kwa ma platelet-derived growth factor receptor (PDGFR [alpha]), KIT, ndi RET.[Zizindikiro]: Lenvatinib ndi oyenera kuchiza odwala a chithokomiro khansa ya m'deralo zisadzachitikenso kapena metastasis mtundu, progressivity mtundu ndi radioactive ayodini-refractory differentiated mtundu.Pa February 13, 2015, US FDA idavomereza Lenvatinib mankhwala ochizira khansa ya chithokomiro.Lenvatinib ndi multi-target enzyme inhibitor, yomwe imatha kuletsa VEGFR2 ndi VEGFR3 (vascular endothelial growth factor receptor).Dzina la malonda la Lenvatinib ndi Lenvima.Pa Meyi 20, 2015, European Medicines Agency (EMA) idavomereza Lenvatinib kuti azitha kuchiza khansa ya chithokomiro, yapapillary, follicular, mtundu wa Hurthle (DTC).M'mayeserowo, nthawi yapakati yopulumuka kwa odwala omwe adalandira chithandizo cha radioactive ayodini-refractory DTC omwe adalandira chithandizo ndi Lenvatinib anali miyezi 18 pomwe mtengo wa odwala omwe atenga placebo ndi miyezi itatu yokha.

Lembani uthenga wanu apa ndikutumiza kwa ife